About QIMI
About QIMI
QIMI is a company registered in the United Kingdom, with a registered address at 42A Tamworth Road, Croydon, Surrey, CR0 1XU. The firm lists its founding date as 11 January 2018, and its official domain is qimi.hk. Although the domain suggests a potential connection to Hong Kong, the registered office and incorporation are in the UK.
Despite its UK registration, QIMI does not appear to operate under any recognised financial regulatory framework. The company's name and domain provide little indication of its specific business activities, and there is no publicly available information regarding the services it offers to clients.
Regulatory Status
Our records show that QIMI does not hold any regulatory licences from major financial authorities such as the Financial Conduct Authority (FCA) in the UK, the Cyprus Securities and Exchange Commission (CySEC), or any other reputable regulator. The absence of regulation is a significant factor for any entity that purports to offer financial services, including forex or CFD trading.
Without regulatory oversight, clients have no recourse to an ombudsman or compensation scheme if disputes arise. This lack of protection is a critical consideration for traders, as unregulated brokers may not adhere to standard practices such as client fund segregation or transparent pricing. The severe scam risk score of 85/100 assigned by FXCanary reflects the heightened danger associated with dealing with an unverified entity.
Company Information
The registered address in Croydon is a standard residential/commercial location, which is sometimes used by companies that do not maintain a physical office presence. The company was incorporated in 2018, meaning it has been in existence for several years, yet there is no substantial documentation of its operations or track record.
Given the limited public information and the absence of any verifiable activity, QIMI's credibility remains unestablished. Prospective clients are urged to exercise extreme caution, as the lack of transparency and regulatory oversight poses significant risks to any funds entrusted to this firm.
Overview compiled by FXCanary from regulatory records and public data. full QIMI review